酶驱动的状纳米反应器使得瘤特异性,级联增强的前药激活,用于协同氧化-化疗-免疫疗法
Xin Li1, Lili Sun2, Xianling Liu2
1Department of General Surgery, The Second Hospital of Lanzhou University & The Second Clinical Medical School, Lanzhou University, Lanzhou 730000, China; Gansu Province Hepatobiliary Pancreatic Disease Precision Diagnosis and Treatment Engineering Research Center, Lanzhou 730000, China.
概括
以酶为动力的纳米反应器激活癌症前药物,特别是在瘤中. 这种策略增强了药物输送,并结合了氧化,化疗和免疫疗法,以改善胰腺癌治疗.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 预制药纳米药物可以改善药物输送,但往往在体内激活不良.
- 有限的治疗疗效与疾病部位的低最佳前药激活有关.
研究的目的:
- 设计由酶驱动的,pH敏感的纳米反应器,用于放大瘤特异性前药激活.
- 开发一种用于胰腺癌的协同氧化-化疗-免疫疗法.
主要方法:
- 葡萄糖氧化酶 (GOD) 封装在与帕克利塔塞尔结合的聚合物微粒中.
- 利用酸性瘤微环境进行局部氧化突发和pro-paclitaxel裂变.
- 使用piperidine功能化的纳米反应器,以提高酶的可访问性和催化.
主要成果:
- 在体外研究表明,在酸性条件下强大的细胞毒性和免疫细胞死亡 (ICD) 诱导.
- 在体内实验证明了高效的瘤特异性前药激活和氧化微环境重塑.
- 在胰腺癌模型中,结合抗PD-1 阻断的联合治疗实现了显著的瘤回归和生存延长.
结论:
- 纳米反应器驱动的级联增强前药激活是胰腺癌的有希望的策略.
- 这种方法可以克服癌症治疗中的药理和免疫学障碍.
- 开发的系统为协同氧化-化疗-免疫疗法提供了一个简单的战略.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K